Connor, Clark & Lunn Investment Management (CC&L)
NXGN

Connor, Clark & Lunn Investment Management (CC&L)’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-92,298
Closed -$1.5M – 1602
2023
Q2 		$1.5M Buy
92,298
+53,474
+138% +$886K 0.01% 683
2023
Q1 		$676K Buy
+38,824
New +$698K ﹤0.01% 805
2022
Q3 		– Sell
-28,436
Closed -$496K – 1279
2022
Q2 		$496K Sell
28,436
-18,494
-39% -$353K ﹤0.01% 780
2022
Q1 		$981K Buy
46,930
+23,697
+102% +$454K ﹤0.01% 665
2021
Q4 		$413K Buy
+23,233
New +$373K ﹤0.01% 834
2020
Q1 		– Sell
-35,585
Closed -$572K – 1207
2019
Q4 		$572K Sell
35,585
-53,928
-60% -$891K ﹤0.01% 645
2019
Q3 		$1.4M Sell
89,513
-28,300
-24% -$471K 0.01% 484
2019
Q2 		$2.34M Buy
117,813
+15,927
+16% +$297K 0.02% 405
2019
Q1 		$1.72M Sell
101,886
-39,850
-28% -$691K 0.01% 444
2018
Q4 		$2.15M Sell
141,736
-31,284
-18% -$537K 0.01% 404
2018
Q3 		$3.47M Buy
173,020
+90,745
+110% +$1.92M 0.02% 361
2018
Q2 		$1.6M Buy
82,275
+68,400
+493% +$1.08M 0.01% 524
2018
Q1 		$189K Buy
+13,875
New +$183K ﹤0.01% 660
2017
Q3 		– Sell
-46,000
Closed -$792K – 941
2017
Q2 		$792K Sell
46,000
-5,700
-11% -$86.6K 0.01% 537
2017
Q1 		$788K Sell
51,700
-4,500
-8% -$66.3K 0.01% 538
2016
Q4 		$739K Sell
56,200
-19,100
-25% -$245K 0.01% 539
2016
Q3 		$852K Buy
75,300
+19,900
+36% +$239K 0.01% 487
2016
Q2 		$660K Buy
+55,400
New +$745K ﹤0.01% 536
2016
Q1 		– Sell
-24,500
Closed -$395K – 915
2015
Q4 		$395K Buy
+24,500
New +$358K ﹤0.01% 585

Other funds holding NXGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s NXGN Position: Q3 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q3 2023, closing a stake of 92,298 shares — an estimated $1.5M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in NXGN in Q4 2015 and held it in 19 quarters. The position peaked at $3.47M in Q3 2018. 214 funds tracked by Wall St. Rank hold NXGN as of Q3 2023.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 92,298 NextGen Healthcare, Inc. Common Stock shares in Q3 2023, an estimated $1.5M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in NextGen Healthcare, Inc. Common Stock in Q4 2015 and held it in 19 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s NextGen Healthcare, Inc. Common Stock position peaked at $3.47M in Q3 2018.
  • 214 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q3 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2023, filed 13 Nov 2023.